Participate in a research project

Please visit our current research projects to see which projects we are actively recruiting patients for.

Participating patients will generally be required to provide a blood sample that will be collected by a fully trained phlebotomist or medical practitioner. Some individuals may experience mild bruising however this generally resolves within 1-3 days.

If you, or someone you know, would like to participate in our research please contact us.

Latest

End of Financial Year Appeal

Your End of Financial Year gift will allow our scientists to continue to develop world-class research into blood disorders and enable our clinical trials unit to continue to grow.
Elie's Story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor.
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab (Cancer - Recruitment: OPEN)

A Phase 1/2, Dose Escalation and Expansion Study of BGB-10188, a Phosphatidylinositol 3-Kinase Delta (PI3Kδ) Inhibitor, Combined With Zanubrutinib in Patients With Mature B-Cell Malignancies and Combined With Tislelizumab in Patients With Solid Tumors.
Create your #Thirty4Thrombosis fundraising page!

Information on how to set up a fundraising page for the Thirty4Thrombosis appeal.

Accessibility
Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists.
Multiple Myeloma Clinical Trials Appeal

PBI is committed to developing new treatments for blood cancers and facilitates patient participation in clinical trials to access potentially lifesaving treatments not currently available elsewhere. Your support will enable us to participate in testing new treatment options to improve the health outcomes for patients with blood disorders, including multiple myeloma.
Privacy Policy

THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.
End of Financial Year Appeal

Your End of Financial Year gift will allow our scientists to continue to develop world-class research into blood disorders and enable our clinical trials unit to continue to grow.
Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Elie's Story

When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor.
COVID-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
COVID-19 Procedures

Information for current/prospective clinical trials patients regarding our COVID-19 procedures.
Make a bequest

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise